2023 European Capital of Innovation announced: Lisbon and Linköping are the winners of this year's iCapital Awards

The European Commission has revealed today the winners of the European Capital of Innovation Awards (iCapital), with the main prizes going to the cities of Lisbon and Linköping. Moreover, the 1st and 2nd runners up have been also announced as follows:

The European Capital of Innovation category:
Lisbon (Portugal) - winner
Warsaw (Poland) - 1st runner up
Lviv (Ukraine) – 2nd runner up

The European Rising Innovative city category:
Linköping (Sweden) - winner
Padova (Italy) – 1st runner up
Cork (Ireland) – 2nd runner up

This event was part of the opening for the Aix Marseille Provence Metropole (AMP) innovation week, and it included the conference “Share the future” and the awards ceremony for the “Prix des possibles”, organised by AMP and inspired by the iCapital awards, to support local innovators. High-level experts and policy makers had the opportunity to discuss production of the energy of the future, protecting water resources, supporting innovators, and creating the Mediterranean sustainable city.


RAPID, IP/23/6016, 27.11.2023
Tagged as:

You may also be interested

EIC Pathfinder Challenges 2026

Horizon Europe. EIC Grants. European Innovation Council. EIC Pathfinder Challenges 2026. Calls for proposals: Advanced Materials for Miniaturised Energy Harvesting Systems. HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-01 Biotechnology for Healthy Ageing. HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-02 DeepRAP: Deep Reasoning, Abstraction & Planning towards trustworthy Cognitive AI Systems. HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-03.
Deadline:
28.10.2026
W3 Funding opportunities and calls for proposals, 22.07.2026

Innovative Health Initiative JU Call 13

Horizon Europe. Research and Innovation Actions. Innovative Health Initiative JU Call 13: IHI European HealthCare Incubator Network. HORIZON-JU-IHI-2026-13-two-stage-01 An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies. HORIZON-JU-IHI-2026-13-two-stage-02 Decode the Immunoscience of age-related diseases. HORIZON-JU-IHI-2026-13-two-stage-03.
Deadline:
08.10.2026
W3 Funding opportunities and calls for proposals, 02.07.2026
envelopeprinter